Leptin mediates the regulation of muscle mass and strength by adipose tissue
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Adipose tissue secretes numerous cytokines (termed ‘adipokines’) that have known or hypothesized actions on skeletal muscle. The majority of adipokines have been implicated in the pathological link between excess adipose and muscle insulin resistance, but approximately half also have documented in vitro effects on myogenesis and/or hypertrophy. This complexity suggests a potential dual role for adipokines in the regulation of muscle mass in homeostasis and the development of pathology. In this study, we used lipodystrophic ‘fat‐free’ mice to demonstrate that adipose tissue is indeed necessary for the development of normal muscle mass and strength. Fat‐free mice had significantly reduced mass (∼15%) and peak contractile tension (∼20%) of fast‐twitch muscles, a slowing of contractile dynamics and decreased cross‐sectional area of fast twitch fibres compared to wild‐type littermates. These deficits in mass and contractile tension were fully rescued by reconstitution of ∼10% of normal adipose mass, indicating that this phenotype is the direct consequence of absent adipose. We then showed that the rescue is solely mediated by the adipokine leptin, as similar reconstitution of adipose from leptin‐knockout mice fails to rescue mass or strength. Together, these data indicate that the development of muscle mass and strength in wild‐type mice is dependent on adipose‐secreted leptin. This finding extends our current understanding of the multiple roles of adipokines in physiology as well as disease pathophysiology to include a critical role for the adipokine leptin in muscle homeostasis. image Key points: Adipose‐derived cytokines (adipokines) have long been implicated in the pathogenesis of insulin resistance in obesity but likely have other under‐appreciated roles in muscle physiology. Here we use a fat‐free mouse to show that adipose tissue is necessary for the normal development of muscle mass and strength. Through add‐back of genetically modified adipose tissue we show that leptin is the key adipokine mediating this regulation. This expands our understanding of leptin's role in adipose–muscle signalling to include development and homeostasis and adds the surprising finding that leptin is the sole mediator of the maintenance of muscle mass and strength by adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 1×
“Such a mechanism has been demonstrated for leptin’s action on skeletal muscle fatty acid oxidation, where early activation of AMP-activated protein kinase is mediated directly by leptin and later activation is indirect through sympathetic stimulation (Minokoshi et al., 2002).”
BackgroundLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038 · cited 1×
“…doses of leptin (to match WT serum levels) reverses insulin resistance (Pelleymounter et al., 1995), as it does in lipodystrophic mice and humans (Petersen et al., 2002; Shimomura et al., 1999), suggesting this could be the mechanism of action of muscle mass accretion with leptin treatment.”
BackgroundYe, J., Gao, Z., Yin, J., & He, Q. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00435.2007 · Cited by 840
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800 · cited 1×
“…doses of leptin (to match WT serum levels) reverses insulin resistance (Pelleymounter et al., 1995), as it does in lipodystrophic mice and humans (Petersen et al., 2002; Shimomura et al., 1999), suggesting this could be the mechanism of action of muscle mass accretion with leptin treatment.”
BackgroundIL-6-induced skeletal muscle atrophy
Haddad, F., Zaldivar, F., Cooper, D. M., & Adams, G. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01026.2004 · Cited by 612
Rosenbaum, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25977 · Cited by 575 · cited 1×
“A number of studies have shown strong, albeit indirect, evidence to support a role for leptin in regulating muscle mass and strength (Rosenbaum et al., 2005).”
ResultCrosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal Muscle
Shimizu, N., Yoshikawa, N., Ito, N., Maruyama, T., Suzuki, Y., Takeda, S.-I., Nakae, J., Tagata, Y., Nishitani, S., Takehana, K., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.001 · Cited by 498
Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle
Frederick, D. W., Loro, E., Liu, L., Davila, A., Chellappa, K., Silverman, I. M., Quinn, W. J., Gosai, S. J., Tichy, E. D., Davis, J. G., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.005 · Cited by 367 · cited 2×
“Many pro-inflammatory adipokines are also secreted bymacrophages (Guilherme et al., 2019), and leptin, adiponectin and visfatin are all also produced by the muscle itself, where these factors are thought to exert autocrine action (Frederick et al., 2016; Krause et al., 2008;Wolsk et al., 2012).”
BackgroundMyokines and Adipokines: Involvement in the Crosstalk between Skeletal Muscle and Adipose Tissue
Li, F., Li, Y., Duan, Y., Hu, C.-A. A., Tang, Y., & Yin, Y. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.10.003 · Cited by 288
Measuring Protein Synthesis With SUnSET: A Valid Alternative to Traditional Techniques?
Goodman, C. A., & Hornberger, T. A. (2013) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3182798a95 · Cited by 233 · cited 2×
“This technique enables protein synthesis rates to be estimated from puromycin quantification in muscle western blots with good correlation to standard radiolabelling methods (Goodman & Hornberger, 2013).”
Method
Research works printed but not linked: 57
- 10.1016/j.nmd.2017.05.015 · doi:10.1016/j.nmd.2017.05.015
- 10.1371/journal.pone.0072330 · DOI · Paper page
- 10.1113/JP279595 · DOI · Paper page
- 10.1016/j.ydbio.2019.11.001 · DOI
- 10.1152/ajpendo.00146.2011 · DOI · Paper page
- 10.1007/s00424-002-0882-1 · DOI
- 10.1002/jmor.1052210207 · DOI · Paper page
- 10.1128/MCB.06465-11 · DOI · Paper page
- 10.1073/pnas.2021096118 · DOI · Paper page
- 10.1016/j.cmet.2009.01.002 · DOI · Paper page
- 10.1111/j.1749-6632.2010.05875.x · DOI · Paper page
- 10.2337/diabetes.50.6.1440 · DOI · Paper page
- 10.1016/j.nutres.2015.07.001 · DOI
- 10.1210/en.2018-00561 · DOI
- Fong Y., 1989, Cachectin/TNF or IL‐1 alpha induces cachexia with redistribution of body proteins, American Journal of Physiology, 256, R659
- 10.2337/diacare.23.10.1545 · doi:10.2337/diacare.23.10.1545
- 10.1038/s41574-019-0165-y · DOI · Paper page
- 10.2337/db11-0915 · DOI · Paper page
- 10.1016/j.bbrc.2010.08.079 · DOI · Paper page
- 10.1016/j.metabol.2013.04.001 · DOI
- 10.1210/en.2005-0731 · DOI · Paper page
- 10.1007/s001250050832 · DOI · Paper page
- 10.1016/j.cbpa.2011.04.007 · DOI
- 10.1007/BF00370217 · DOI
- 10.1073/pnas.1525093113 · DOI · Paper page
- 10.1677/JOE-09-0003 · DOI
- 10.1113/jphysiol.1981.sp013656 · DOI
- 10.1017/S0007114512004849 · DOI
- 10.1016/S0303-7207(02)00427-6 · DOI
- 10.1113/jphysiol.2012.238576 · DOI · Paper page
- 10.1111/obr.12862 · DOI · Paper page
- 10.1002/jcb.21833 · DOI · Paper page
- 10.1016/j.celrep.2016.08.086 · DOI · Paper page
- 10.2337/diab.46.8.1360 · DOI · Paper page
- 10.1186/s12950-018-0185-8 · DOI · Paper page
- 10.1126/science.7624776 · DOI · Paper page
- 10.1210/en.139.10.4264 · doi:10.1210/en.139.10.4264 · Paper page
- 10.1016/B978-0-12-397920-9.00005-6 · DOI
- 10.1210/jc.2010-1408 · DOI · Paper page
- 10.1038/oby.2011.235 · DOI
- Saito M., 1984, Adrenalectomy and food restriction in the genetically obese (ob/ob) mouse, American Journal of Physiology, 246, R20
- 10.1016/j.tem.2006.10.010 · DOI
- 10.1210/en.2005-0969 · DOI · Paper page
- 10.1016/j.febslet.2014.02.027 · DOI
- 10.1210/clinem/dgab725 · DOI
- Smith C. K., 1985, Effects of adrenalectomy on energy balance of obese mice are diet dependent, American Journal of Physiology, 249, R13
- 10.1016/S0021-9258(18)94260-2 · DOI
- 10.1038/31474 · DOI · Paper page
- 10.1097/MCO.0b013e328360272d · DOI · Paper page
- 10.1038/sj.ijo.0801357 · DOI
- 10.1194/jlr.M700195-JLR200 · DOI
- 10.1016/j.cyto.2012.08.021 · DOI
- 10.4049/jimmunol.1701668 · DOI
- 10.1016/j.cyto.2012.07.033 · DOI
- 10.1016/j.gene.2020.145380 · DOI
- 10.7554/eLife.66275 · DOI
- 10.1371/journal.pgen.1008244 · DOI · Paper page
Cited by
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
High-quality weight loss in obesity: importance of skeletal muscle
Harper, M.-E., Dent, R. R. M., & McPherson, R. (2025) · Diabetes · doi:10.2337/dbi25-0003 · Cited by 27
Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2025) · Metabolites · doi:10.3390/metabo15020085 · Cited by 19
“As alluded to earlier, the development of sarcopenia has serious negative consequences for metabolic health and efficiency [43].”
Influential
Metadata
- Authors
- Collins, K. H., Gui, C., Ely, E. V., Lenz, K. L., Harris, C. A., Guilak, F., & Meyer, G. A.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2022-08
- Volume
- 600
- Issue
- 16
- Pages
- 3795-3817
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W4285731511
- Cited by
- 54
- References
- 17
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- National Institutes of Health (AR075773, AG15768, AG46927, AR072999, AR073752, AR071582)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.